Search PubMed⌕ Search

Biomedical subjects

J Potel

Publications and source records attributed to J Potel.

At least 73 records · Page 4Linked to original sources
PubMed1967

[Listeriosis].

Explore the source record for details and available documents.

Humans↗
PubMedDate not supplied

[Experimental study of the local application of silver sulfadiazine, cefsulodin and povidone-iodine in burns].

Non-infected standardized burns and those contaminated experimentally with a constant number of organisms of a selected Pseudomonas aeruginosa strain underwent varying forms of treatment with silver sulfadiazine, cefsulodin cream and povidone iodine ointment. Wound healing was controlled by evaluating the wound area. In burns which had not been infected experimentally, healing was best without any treatment. Burns treated with cefsulodin cream showed delayed healing, though this was not significant. The most significant delay, however, was observed in wounds treated with povidone iodine. Wounds infected with Pseudomonas healed considerably better than the control group when treated prophylactically with silver sulfadiazine and cefsulodin. However, burns treated with povidone iodine again showed delayed healing.

Administration, Topical↗
PubMedDate not supplied

[Microbiological studies with the new penicillin BRL 17421 (temocillin)].

In vitro Evaluation of BRL 17421 (Temocillin), a New Penicillin. The in vitro antibacterial activity of BRL 17421 (temocillin), a new penicillin, was determined in quantitative serial broth dilution tests and was compared to that of mezlocillin, piperacillin, cefazolin and cefotaxime against 751 clinical isolates of the Enterobacteriaceae family. In addition, the sensitivity of 211 mezlocillin-resistant gram-negative rods to BRL 17421 was also determined. Temocillin exhibited a high level of antibacterial activity against various bacterial species of the Enterobacteriaceae family, including isolates resistant to mezlocillin. The 90% MICs against Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii, Enterobacter cloacae, Salmonella spp., Yersinia spp. and indole-negative and indole-positive Proteus strains ranged from 0.5 mg/l to 16 mg/l. Concentrations of 16 mg/l were required to inhibit 80% of the Serratia marcescens strains; some isolates were resistant. No significant difference between MIC and MBC values was observed.

Cefazolin↗